The New Taipei City Social Welfare Department on Thursday celebrated Paralympic competitor Chen Tzu-wei (張孜維), who received last year’s national Golden Eagle award for exemplary achievement by ...

Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.

Medera Inc. ('Medera'), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

She and her family weren’t planning to stay, but between her pessimism about receiving grant funding and her anxiety about the immigration crackdown given her own status as a green card holder, they ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people. While it is well known for causing muscle weakness and stiffness, DM1 also ...

JCR Pharmaceuticals and Italfarmaco announced an exclusive licensing agreement for the development and commercialization of givinostat in Japan.

Strength training supports healthy aging by preserving muscle, bone density, metabolic health, and independence.

Deborah Johnson recalled drawing a picture for a magazine art contest while growing up. "A friend mailed it in, and I got response that I was too young for the art school," she said. "I wasn’t ...